Validation of Velocity Curvature Index as a Diagnostic Biomarker Tool for Assessment of Large Vessel Stroke

TerminatedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

September 21, 2022

Primary Completion Date

January 16, 2023

Study Completion Date

January 31, 2023

Conditions
StrokeAcute Ischemic Stroke
Interventions
DEVICE

NovaGuide 2 Intelligent Ultrasound System

The NovaGuide 2 Intelligent Ultrasound system is an adjunctive mobile, non-invasive, non-ionizing radiation transcranial Doppler (TCD) diagnostic ultrasound system. The system contains a transcranial doppler ultrasound equipment combined with robotic mechanisms used to position ultrasound probes, which assist the user in the acquisition of cerebral blood flow velocity (CBFV) data via a patient's temporal acoustic windows.

Trial Locations (1)

37404

CHI Memorial Hospital, Chattanooga

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

NovaSignal Corp.

INDUSTRY

NCT05547412 - Validation of Velocity Curvature Index as a Diagnostic Biomarker Tool for Assessment of Large Vessel Stroke | Biotech Hunter | Biotech Hunter